Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)

Completed · Not applicable

Conditions studied: Ovarian Cancer

In brief

To compare the feasibility and surgical outcomes between complete salpingectomy and standard postpartum tubal ligation (partial salpingectomy) at the time of cesarean delivery in women with undesired future fertility. as a possible ovarian cancer risk-reducing procedure.

Key facts

Study ID

NCT02374827

Run by

University of Alabama at Birmingham

People needed

80

Starts

2015-04-01

Expected to finish

2017-09-01

Last updated by the study team

2017-10-05

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• All pregnant women > 25 years receiving prenatal care within the UAB Health System, and planning to undergo tubal ligation at the time of their scheduled cesarean delivery (primary or repeat)
• Informed consent obtained

You may not qualify if…

• Inability to obtain informed consent
• Fetal death or anomalies
• Preterm delivery < 36 weeks gestation
• Immune-compromising disease
• Chronic steroid use
• Chronic prophylactic or therapeutic anti-coagulation
• Patients no followed in our regional health system
• Known BRCA mutation carrier status
• Age < 25 years

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.